Innovation Pte. Ltd. 6/ Others items and elimination As for the performance of the first 9 months of 2018, Bangchak Corporation Plc. (“The Company”) and its subsidiaries recorded revenue from sale of goods and
PUBLIC COMPANY LIMITED BANGKOK DEC - CON PUBLIC COMPANY LIMITED BANGKOK DUSIT MEDICAL SERVICES PUBLIC COMPANY LIMITED BANGKOK EXPRESSWAY AND METRO PUBLIC COMPANY LIMITED BANGKOK GENOMICS INNOVATION PUBLIC
BANGKOK DUSIT MEDICAL SERVICES PUBLIC COMPANY LIMITED BANGKOK EXPRESSWAY AND METRO PUBLIC COMPANY LIMITED BANGKOK EXPRESSWAY PUBLIC COMPANY LIMITED BANGKOK GENOMICS INNOVATION PUBLIC COMPANY LIMITED BANGKOK
livestock animal products, together with a rise in revenues from sales of healthcare products and aesthetic innovation products for human from Baht 224.58 million in 2018 to Baht 229.87 million or 2.36% in
development in order to bring technology and innovation to develop the Company's projects and services to maximize customers’ satisfaction. Also, it is a good opportunity to expand overseas markets in the
between each other and to cooperate in research and development in order to bring technology and innovation to develop the Company's projects and services to maximize customers’ satisfaction. Also, it is a
ZIGA Innovation Public Company Limited ("the Company") would like to clarify operating performance of the Company three-month for the Quarter 2/2017 and consolidated financial statements ended 30th June
เทคโนโลยี (Yes to Digital Asset Innovation, No to Cryptocurrency Speculation) โดยมีแนวคิดที่จะพัฒนาระบบนิเวศของสินทรัพย์ดิจิทัล (digital asset ecosystem) และใช้ประโยชน์จากเทคโนโลยี DLT ซึ่งถือเป็นวาระหลักใน
to encourage more innovation and adaptive to the dynamic environment. Secondly, on digital assets and crypto currencies. Within the financial markets, digital assets and crypto currencies are among the